• New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

    28 days ago - By News Medical

    A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.
    Read more ...

     

  • New Nanoplatform Technology Offers Hope in Treating Drug-resistant Renal Cell Carcinoma

    New Nanoplatform Technology Offers Hope in Treating Drug-resistant Renal Cell Carcinoma

    29 days ago - By Medindia Health

    The tumor hypoxia directed nanoparticle used in conjunction with the FDA-approved renal cell carcinoma treatment, Sorafenib had positive outcomes in animal trials.
    Read more ...